Product Program year 2020 Source: CMS Open Payments

V114

Biological Vaccine

Open in the dashboard

General payments

$207,048

765 payments

Research payments

$40,629,271

11,249 payments

Through program year 2020, $207,048 in general payments and $40,629,271 in research payments were reported against V114 (Vaccine).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

4 rows
Year Kind Amount Payments
2020 General $69,389 56
2020 Research $12,457,630 4,147
2019 General $137,659 709
2019 Research $28,171,641 7,102

Breakdown

Who paid General payments · program years 2019–2020
  1. Merck Sharp & Dohme Corporation $207,048 765 payments
Top recipients General payments · program year 2020
  1. Gregory Poland Internal Medicine · Rochester, MN $46,250 67% · 7 payments
  2. Chihiro Morishima Clinical & Laboratory Immunology · Seattle, WA $5,106 7% · 5 payments
  3. Robert Jacobson Pediatrics · Rochester, MN $3,938 6% · 6 payments
  4. Robert Bollinger Infectious Disease · Baltimore, MD $3,804 5% · 4 payments
  5. Camille Kotton Infectious Disease · Boston, MA $2,231 3% · 3 payments

The top 5 of 12 recipients; each share is of general payments naming this product in 2020.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2020
  1. Internal Medicine $47,250 68% · 2 practitioners
  2. Infectious Disease Internal Medicine $8,266 12% · 3 practitioners
  3. Clinical & Laboratory Immunology Internal Medicine $5,106 7% · 1 practitioner
  4. Pediatrics $3,938 6% · 1 practitioner
  5. Pediatric Infectious Diseases Pediatrics $3,291 5% · 3 practitioners

The top 5 of 7 specialties; each share is of general payments naming this product to practitioners with a specialty in 2020. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2020
  1. Minnesota $52,419 76% · 3 recipients
  2. Washington $5,106 7% · 1 recipient
  3. Maryland $4,341 6% · 2 recipients
  4. Massachusetts $3,081 4% · 2 recipients
  5. Illinois $1,550 2% · 1 recipient

The top 5 of 8 states; each share is of general payments naming this product in 2020 where a state was reported.

The top 25 states, free in the app

765 general · 11,249 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2020

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record